CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 71 enrolled
Drug / intervention
Transcatheter Aortic Valve Replacementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05002088
NCT05002088N/ACompleted
CompareCT.gov

Retrospective Assessment of the Portico Transcatheter Aortic Valve for Valve-in-Valve Use

Abbott Medical Devices·observational·Posted Aug 12, 2021·Updated Feb 28, 2025

In Brief

An observational study evaluating Transcatheter Aortic Valve Replacement for Aortic Valve Stenosis and 3 related conditions. Completed, enrolled 71 participants across 7 sites in 4 countries.

Detailed Summary

The objective of this data-collection study is to retrospectively evaluate the safety and clinical performance of the Portico transthoracic aortic valve for Valve-in-Valve treatment of a failed aortic surgical bioprosthetic valve in patients who are considered at increased surgical risk for a redo surgical aortic valve replacement.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis, Aortic Valve Failure, Aortic Insufficiency, Aortic Stenosis
CountriesAustralia, Denmark, Germany, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 12, 2021
Enrollment StartOct 21, 2021
Primary CompletionDec 29, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 4.9 years ago

Interventions

Transcatheter Aortic Valve Replacementdevice

Transcatheter Aortic Valve Replacement for the treatment of a failed surgical aortic valve bioprosthesis, Valve-in-Valve (ViV), in patients who were considered to be at increased risk for redo surgical aortic valve replacement